# Pfizer Inc. (PFE) — Q4-2019 Earnings Results

**Report date:** 2020-01-28 (before market open)  
**Sector:** Health Care / Pharmaceuticals  
**Status:** reported  
**Source:** https://earningsnxt.ai/ticker/PFE/earnings/Q4-2019

## Post-Earnings Brief

### Headline

Pfizer Misses on EPS — Stock Down 5.03%

### Key Numbers

| Metric | Actual | Expected | Surprise |
|---|---|---|---|
| EPS | $0.55 | N/A | -9.32% |
| Revenue | N/A | N/A | N/A |

### Management Commentary

**Tone:** Defensive

Overall, management expressed caution regarding market conditions. They highlighted ongoing investments in research and development.

**Key quotes:**

> Management noted challenges in the competitive landscape.

> They emphasized a focus on pipeline development moving forward.

### Guidance Changes

No forward guidance was provided during the earnings call.

### What It Means

Pfizer's earnings report showed a miss on EPS, which contributed to a 5.03% decline in stock price. The lack of revenue details and guidance may raise concerns among investors about the company's future performance. Management's cautious tone suggests they are aware of challenges ahead but remain focused on their product pipeline.

---

_AI-assisted analysis from EarningsNxt. Not financial advice. View full page: https://earningsnxt.ai/ticker/PFE/earnings/Q4-2019_